Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Federico

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
AJOB Empirical Bioethics|April 8, 2024
Moral Engagement and Disengagement in Health Care AI DevelopmentAriadne A Nichol, Meghan Halley, Carole Federico, et al.
Plos Biology|April 6, 2018
Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment?Susanne Wieschowski, William Wei Lim Chin, Carole Federico, et al.
British Journal of Pharmacology|August 29, 2018
Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional studyHolger Langhof, William Wei Lim Chin, Susanne Wieschowski, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
AJOB Empirical Bioethics|April 8, 2024
Moral Engagement and Disengagement in Health Care AI DevelopmentAriadne A Nichol, Meghan Halley, Carole Federico, et al.
Plos Biology|April 6, 2018
Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment?Susanne Wieschowski, William Wei Lim Chin, Carole Federico, et al.
British Journal of Pharmacology|August 29, 2018
Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional studyHolger Langhof, William Wei Lim Chin, Susanne Wieschowski, et al.
Pageof 1